title: Successful approach to treatment of Helicobacter bilis infection in X-linked agammaglobulinemia.
abstract: Helicobacter bilis, an unusual cause of chronic infections in patients with X-linked agammaglobulinemia (XLA), is notoriously difficult to diagnose and eradicate. Based on the limited number of cases reported worldwide, we highlight the typical features of H. bilis infection in XLA and provide a rational and successful approach to diagnosis and treatment of this challenging infection.
authors: Department of Pediatrics, BC Children's Hospital and Child & Family Research Institute, University of British Columbia, Vancouver, BC, Canada. sturvey@cw.bc.ca
authors: Stuart E
authors: SE
authors: Turvey
authors: Sara H
authors: SH
authors: Leo
authors: Annette
authors: A
authors: Boos
authors: Gregory D
authors: GD
authors: Deans
authors: Julie
authors: J
authors: Prendiville
authors: Richard I
authors: RI
authors: Crawford
authors: Christof
authors: C
authors: Senger
authors: Mary Ellen
authors: ME
authors: Conley
authors: Peter
authors: P
authors: Tilley
authors: Anne
authors: A
authors: Junker
authors: Loretta
authors: L
authors: Janz
authors: Robert
authors: R
authors: Azana
authors: Linda
authors: L
authors: Hoang
authors: Tracy L
authors: TL
authors: Morton
mesh_terms: D000293:Adolescent; D000328:Adult; D000361:Agammaglobulinemia / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017963:Azithromycin / Q000627:therapeutic use*; D002908:Chronic Disease; D000077727:Ertapenem; D040181:Genetic Diseases, X-Linked / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D016998:Helicobacter / Q000187:drug effects* / Q000235:genetics / Q000472:pathogenicity; D016481:Helicobacter Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008297:Male; D015242:Ofloxacin / Q000627:therapeutic use*; D010802:Phylogeny; D016896:Treatment Outcome; D047090:beta-Lactams / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D047090:beta-Lactams; D017963:Azithromycin; D015242:Ofloxacin; D000077727:Ertapenem